*Department of Obstetrics and Gynecology, School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan.
Jpn J Clin Oncol. 2014 Jan;44(1):49-56. doi: 10.1093/jjco/hyt171. Epub 2013 Nov 11.
This study aimed to examine family history among Japanese ovarian cancer patients and to investigate the TP53 status of fallopian tube epithelial and ovarian cancer cells in a Japanese BRCA1 mutant case that may be associated with the transformed state in hereditary ovarian cancer.
One hundred and two primary ovarian cancer patients were retrospectively evaluated in this cross-sectional study. The family history of cancer was determined in probands. In a BRCA1 mutant case, p53 immunostaining and direct sequencing, followed by laser-capture microdissection, were performed for the fallopian tube, considered the origin of ovarian cancer.
Nine of 102 (8.8%) families were regarded as having hereditary breast-ovarian cancer syndrome, two families (2.0%) were diagnosed with Lynch syndrome and six patients harbored BRCA1 or BRCA2 mutations. One case underwent risk-reductive salpingo-oophorectomy as a BRCA1 mutant carrier was retrospectively diagnosed as occult cancer. Common TP53 mutations were detected in cancer and fallopian tube epithelial cells in the case.
Here, we integrate family cancer history and histology in ovarian cancer cases as well as TP53 status in a BRCA1 mutant case into a discussion regarding carcinogenesis in a Japanese population. The TP53 status for the BRCA1 mutant case examined here supports the recently proposed theory that ovarian cancer develops because of BRCA1 or BRCA2 inactivation and/or TP53 mutations.
本研究旨在研究日本卵巢癌患者的家族史,并调查可能与遗传性卵巢癌转化状态相关的 BRCA1 突变病例中输卵管上皮和卵巢癌细胞的 TP53 状态。
在这项回顾性的病例研究中,我们对 102 名原发性卵巢癌患者进行了评估。在先证者中确定了癌症的家族史。在 BRCA1 突变病例中,进行了 p53 免疫组化和直接测序,随后进行了激光捕获微切割,用于研究输卵管,这被认为是卵巢癌的起源。
9 个家族(8.8%)被认为患有遗传性乳腺癌-卵巢癌综合征,2 个家族(2.0%)被诊断为林奇综合征,6 名患者携带 BRCA1 或 BRCA2 突变。一个病例作为 BRCA1 突变携带者进行了风险降低的输卵管卵巢切除术,该病例被回顾性诊断为隐匿性癌症。在该病例中,在癌症和输卵管上皮细胞中检测到常见的 TP53 突变。
在这里,我们将卵巢癌病例中的家族癌症史和组织学以及 BRCA1 突变病例中的 TP53 状态综合起来,讨论了日本人群中的癌症发生机制。我们研究的 BRCA1 突变病例的 TP53 状态支持了最近提出的理论,即卵巢癌的发生是由于 BRCA1 或 BRCA2 失活和/或 TP53 突变。